Phoenixville, PA, United States of America

Kathleen J Illig

This inventor holds 7 USPTO granted patents, plus 1 CIPO patent. Top assignees: Nanosystems L.l.c., Merck + Co., Inc., Elan Pharma International Limited. Active years: 1994-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kathleen J Illig. Retrieved from https://idiyas.com/inventor/kathleen-j-illig

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.5

ph-index = 5

Forward Citations = 594(Granted Patents)


Company Filing History:


Years Active: 1994-2003

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Kathleen J. Illig

Introduction

Kathleen J. Illig is a prominent inventor based in Phoenixville, PA, known for her significant contributions to the field of antibiotic formulations. With a total of seven patents to her name, she has made remarkable strides in the development of carbapenem antibiotic compositions.

Latest Patents

Among her latest patents are the "Process for formulation of carbapenem antibiotic compositions" and the "Process for formulation of antibiotic compounds." These innovations reflect her dedication to improving antibiotic efficacy and safety.

Career Highlights

Kathleen has worked with notable companies such as Nanosystems LLC and Merck & Company, Inc. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in pharmaceuticals.

Collaborations

Throughout her career, Kathleen has collaborated with esteemed colleagues, including Pramod P. Sarpotdar and Gary G. Liversidge. These partnerships have further enhanced her innovative capabilities and expanded her impact in the field.

Conclusion

Kathleen J. Illig's work exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions to antibiotic formulations are invaluable and continue to influence the development of effective treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…